China Pharma Holdings (CPHI) Other Working Capital Changes (2010 - 2026)
China Pharma Holdings (CPHI) reported Other Working Capital Changes of -$51376.0 for Q1 2026, down 6.99% on a YoY basis from -$55237.7 in Q1 2025, and down 985.49% quarter-over-quarter from $5802.0 in Q4 2025.
China Pharma Holdings (CPHI) Other Working Capital Changes (2010 - 2026) Analysis & Trends
China Pharma Holdings has reported Other Working Capital Changes for 17 years, with the latest figure at -$51376.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes fell 6.99% year-over-year to -$51376.0; the trailing twelve-month figure through Mar 2026 stood at -$4150.0 (up 93.91% YoY), and the FY2025 full-year result was -$793.0, down 101.08% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$51376.0, down from $5802.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $365501.0 in Q4 2023, with the low at -$483110.0 in Q2 2023.
- Historically, Other Working Capital Changes has averaged $22723.2 across 5 years, with a median of $9414.0 in 2022.
- The largest YoY upside for Other Working Capital Changes was 6622.62% in 2023 against a maximum downside of 1967.67% in 2023.
- China Pharma Holdings' Other Working Capital Changes stood at $302614.0 in 2022, then increased by 20.78% to $365501.0 in 2023, then sank by 80.58% to $70996.0 in 2024, then slumped by 91.83% to $5802.0 in 2025, then sank by 985.49% to -$51376.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$51376.0 (Q1 2026), $5802.0 (Q4 2025), and $178.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | China Pharma Holdings | 19.13 Mn | 18.97 Mn | 285,487.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -51,376.00 |
| Mar 31, 2026 | -51,376.00 |
| Dec 31, 2025 | 5,802.00 |
| Dec 31, 2025 | 5,802.00 |
| Sep 30, 2025 | 178.00 |
| Sep 30, 2025 | 178.00 |
| Jun 30, 2025 | 41,246.00 |
| Jun 30, 2025 | 41,246.00 |
| Mar 31, 2025 | -48,019.00 |
| Mar 31, 2025 | -48,019.00 |
| Dec 31, 2024 | 70,996.00 |
| Dec 31, 2024 | 70,996.00 |
| Sep 30, 2024 | -3,333.00 |
| Sep 30, 2024 | -3,333.00 |
| Jun 30, 2024 | -87,776.00 |
| Jun 30, 2024 | -87,776.00 |
| Mar 31, 2024 | 93,829.00 |
| Mar 31, 2024 | 93,829.00 |
| Dec 31, 2023 | 365,501.00 |
| Dec 31, 2023 | 365,501.00 |